Spots Global Cancer Trial Database for malignant neoplasms
Every month we try and update this database with for malignant neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors | NCT04343859 | Malignant Neopl... | IMMH-010 | 18 Years - | Tianjin Chasesun Pharmaceutical Co., LTD | |
| A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement | NCT04543188 | Malignant Melan... Carcinoma, Non-... Brain Neoplasms... Brain Neoplasms Malignant Neopl... | PF-07284890 Binimetinib Midazolam | 16 Years - | Pfizer | |
| DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
| A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors | NCT05538130 | Melanoma Glioma Thyroid Cancer Non-Small Cell ... Malignant Neopl... Brain Neoplasms Colorectal Canc... | PF-07799544 PF-07799933 encorafenib | 16 Years - | Pfizer | |
| A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors | NCT05315180 | Malignant Neopl... Metastatic Canc... | BPI-421286 | 18 Years - 75 Years | Betta Pharmaceuticals Co., Ltd. | |
| A Multi Center Study of Sexual Toxicities After Radiotherapy | NCT05394428 | Malignant Neopl... | No intervention | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients | NCT04202848 | Lung Cancer Breast Cancer Gastrointestina... Malignant Neopl... | Flora analysis | 18 Years - 85 Years | The First Affiliated Hospital of Dalian Medical University | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer | NCT02922764 | Endometrial Can... Endometrial Can... Lung Cancer Rec... Lung Cancer Non-small Cell ... Non-small Cell ... | RGX-104 Ipilimumab Docetaxel Pembrolizumab Carboplatin Pemetrexed | 18 Years - | Inspirna, Inc. | |
| A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors | NCT05538130 | Melanoma Glioma Thyroid Cancer Non-Small Cell ... Malignant Neopl... Brain Neoplasms Colorectal Canc... | PF-07799544 PF-07799933 encorafenib | 16 Years - | Pfizer | |
| DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | NCT05768178 | Solid Tumor Haematological ... Melanoma Thyroid Cancer,... Ovarian Neoplas... Colorectal Neop... Laryngeal Neopl... Carcinoma, Non-... Glioma Multiple Myelom... Erdheim-Chester... Thyroid Carcino... | Vemurafenib Cobimetinib | 18 Years - | Cancer Research UK | |
| A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors | NCT05315180 | Malignant Neopl... Metastatic Canc... | BPI-421286 | 18 Years - 75 Years | Betta Pharmaceuticals Co., Ltd. | |
| A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors | NCT04343859 | Malignant Neopl... | IMMH-010 | 18 Years - | Tianjin Chasesun Pharmaceutical Co., LTD | |
| Community Cancer Centers Pilot Patient Survey | NCT00786656 | Malignant Neopl... Cancer | 21 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| PAS-004 in Patients With Advanced Solid Tumors | NCT06299839 | RAS Mutation NF1 Mutation RAF Mutation Advanced Solid ... | PAS-004 | 18 Years - | Pasithea Therapeutics Corp. | |
| Validation of the Italian Version of the PRO-CTCAE | NCT04416672 | Malignant Neopl... | PRO-CTCAE items | 18 Years - | National Cancer Institute, Naples | |
| DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. | NCT05770544 | Solid Tumor Haematological ... Malignancy Malignant Neopl... Lymphoprolifera... Neoplasms by Hi... Neoplasms by Si... Cancer Brain Neoplasms Melanoma Glioma | Entrectinib | - | Cancer Research UK | |
| PAS-004 in Patients With Advanced Solid Tumors | NCT06299839 | RAS Mutation NF1 Mutation RAF Mutation Advanced Solid ... | PAS-004 | 18 Years - | Pasithea Therapeutics Corp. | |
| A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer | NCT04881981 | Malignant Neopl... | SCART radiation... | 18 Years - | Baptist Health, Louisville |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
